Archives of biochemistry and biophysics · 2026
Exosomal miR-93-5p modulates macrophage polarization to enhance prostate cancer progression.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Yarong, Chen Wenjun, Yu Bei, Wang Liang, Tang Wei
Аннотация
BACKGROUND: Prostate cancer (PC) remains a major public health challenge, with emerging evidence suggesting that microRNA-93-5p (miR-93-5p) plays a critical role in cancer progression.
AIM: This study investigated how exosomal miR-93-5p derived from PC cells modulates tumor-associated macrophage (TAM) polarization and influences PC progression, while elucidating the underlying molecular mechanisms.
METHODS: We analyzed miR-93-5p expression levels in PC tissues and serum samples, followed by detailed characterization of PC cell-derived exosomes. Subsequently, we evaluated the capacity of these exosomes to induce macrophage polarization, examined the regulatory relationship between miR-93-5p and suppressor of cytokine signaling 6 (SOCS6), and assessed the activation status of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway.
RESULTS: Elevated miR-93-5p levels in PC tissues and serum were significantly associated with metastatic features. We demonstrated that PC cell-derived exosomes enriched with miR-93-5p effectively reprogram macrophages toward an immunosuppressive M2 phenotype. Mechanistically, this polarization was mediated through miR-93-5p-induced downregulation of SOCS6, a negative regulator of cytokine signaling, leading to subsequent activation of the JAK2/STAT3 pathway, which enhances PC cell motility and invasiveness. Importantly, xenograft experiments confirmed that miR-93-5p-enriched macrophages substantially accelerated tumor growth in vivo.
CONCLUSION: Our findings reveal that exosomal miR-93-5p from PC cells drives M2 macrophage polarization and disease progression through SOCS6 suppression and JAK2/STAT3 pathway activation. These results identify exosomal miR-93-5p as a promising therapeutic target and provide new avenues for developing innovative treatment strategies against PC.
AIM: This study investigated how exosomal miR-93-5p derived from PC cells modulates tumor-associated macrophage (TAM) polarization and influences PC progression, while elucidating the underlying molecular mechanisms.
METHODS: We analyzed miR-93-5p expression levels in PC tissues and serum samples, followed by detailed characterization of PC cell-derived exosomes. Subsequently, we evaluated the capacity of these exosomes to induce macrophage polarization, examined the regulatory relationship between miR-93-5p and suppressor of cytokine signaling 6 (SOCS6), and assessed the activation status of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway.
RESULTS: Elevated miR-93-5p levels in PC tissues and serum were significantly associated with metastatic features. We demonstrated that PC cell-derived exosomes enriched with miR-93-5p effectively reprogram macrophages toward an immunosuppressive M2 phenotype. Mechanistically, this polarization was mediated through miR-93-5p-induced downregulation of SOCS6, a negative regulator of cytokine signaling, leading to subsequent activation of the JAK2/STAT3 pathway, which enhances PC cell motility and invasiveness. Importantly, xenograft experiments confirmed that miR-93-5p-enriched macrophages substantially accelerated tumor growth in vivo.
CONCLUSION: Our findings reveal that exosomal miR-93-5p from PC cells drives M2 macrophage polarization and disease progression through SOCS6 suppression and JAK2/STAT3 pathway activation. These results identify exosomal miR-93-5p as a promising therapeutic target and provide new avenues for developing innovative treatment strategies against PC.